Skip to content
Israeli Founders

healthtech, biotech

Remepy

Hybrid drugs pairing prescription medicine with AI-driven apps; Parkinsons Phase III prep

Total raised
$36M
Funding rounds
1
Founded
2022
Headquarters
Ramat Gan

Remepy is an Israeli healthtech and biotech company1 founded in 20221, headquartered in Ramat Gan1.

It has raised $36M across 1 funding round1; the most recent was a Series A round of $36M1, announced Aug 12, 20261.

Funding history

1 round

Funding rounds raised by Remepy, newest first
RoundAnnouncedAmountLead investors
Series AAug 12, 2026$36MO.G. Venture Partners

Investors

Which Israeli startups are similar to Remepy?

Which startups share investors with Remepy?

Sources

  1. 1CTech, Aug 12, 2026. “Remepy raises $36 million Series A as it prepares AI-driven Parkinson’s treatment for Phase III”

How much funding has Remepy raised?

Remepy has raised $36M across 1 funding round.

What was Remepy’s latest funding round?

Remepy’s most recent round was a Series A round of $36M, announced Aug 12, 2026.

Who has invested in Remepy?

Investors in Remepy include O.G. Venture Partners, NFX, Vine Ventures, TechAviv, 97212 Ventures and Qumra Capital, among others.

When was Remepy founded?

Remepy was founded in 2022 and is headquartered in Ramat Gan, Israel.